Edition:
United Kingdom

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

261.75INR
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
Rs261.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,090,922
52-wk High
Rs337.80
52-wk Low
Rs161.00

Latest Key Developments (Source: Significant Developments)

Suven Life Sciences Gets Product Patents In New Zealand And Sri Lanka
Friday, 14 Sep 2018 

Sept 14 (Reuters) - Suven Life Sciences Ltd ::SAYS GETS PRODUCT PATENTS IN NEW ZEALAND AND SRI LANKA.SUVEN LIFE SCIENCES -PATENTS FOR CHEMICAL ENTITY FOR TREATMENT OF DISORDERS FOR NEURODEGENERATIVE DISEASES; VALID THROUGH 2034 AND 2031 RESPECTIVELY.  Full Article

Suven Life Sciences Gets Product Patents In India, Singapore,South Korea And Israel
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN INDIA, SINGAPORE,SOUTH KOREA AND ISRAEL.SAYS PATENTS ARE VALID THROUGH 2031, 2034, 2034 AND 2036.SUVEN LIFE SCIENCES - GRANT OF PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.  Full Article

Suven Life Sciences Secures Product Patents In New Zealand And USA
Tuesday, 29 May 2018 

May 29 (Reuters) - Suven Life Sciences Ltd ::SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND USA.PATENTS ARE VALID THROUGH 2034.SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.  Full Article

India's Suven Life Sciences March Qtr Profit Rises
Tuesday, 15 May 2018 

May 15 (Reuters) - Suven Life Sciences Ltd ::MARCH QUARTER NET PROFIT 625.1 MILLION RUPEES VERSUS PROFIT 400.7 MILLION RUPEES YEAR AGO.MARCH QUARTER TOTAL REVENUE FROM OPERATIONS 2.14 BILLION RUPEES VERSUS 1.80 BILLION RUPEES YEAR AGO.  Full Article

Suven Life Sciences Says FDA Observed Some Procedures Are Deficient During Medak Unit Inspection
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Suven Life Sciences Ltd ::SUVEN LIFE SCIENCES - FDA DURING INSPECTION OF PASHAMYLARAM, MEDAK UNIT OBSERVED THERE ARE PROCEDURES FOLLOWED ON CERTAIN ASPECTS WHICH ARE DEFICIENT.SAYS CO REVISED STANDARD OPERATING PROCEDURES AS CORRECTIVE ACTION.  Full Article

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article

India's Suven Life Sciences gets product patent in Singapore
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Suven Life Sciences Ltd :Gets product patent from Singapore related to new chemical entities for treating disorders associated with neurodegenerative diseases.  Full Article

Suven Life Sciences gets product patent in New Zealand​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Suven Life Sciences Ltd :Says ‍co secures a product patent in New Zealand​.Says patents are valid through 2034.Product patent corresponds to New Chemical Entities (NCEs) for treatment of disorders associated with neurodegenerative diseases‍​‍​.  Full Article

Suven Life Sciences secures product patents in Israel, Macau and South Korea
Monday, 10 Jul 2017 

July 10 (Reuters) - Suven Life Sciences Ltd ::Says ‍'suven Life Sciences secures product patents in Israel, Macau and South Korea'.​.Says grant of 1 product patent from Israel, 1 product patent from Macau , 1 product patent from South Korea.Suven life sciences says patents of products intended for treatment of disorders related to neurodegenerative diseases; patents valid through 2032.  Full Article